// App-Quantinova.ai

Tu1170 : NMR Urine Metabolomics in the Prediction of Response to Infliximab in Patients With UC and CD

Researchers

Presenter

  • Rae R. Foshaug

Principal Investigators

  • Victor Tso

  • Brian Bressler

  • Shane Devlin

  • Karen I. Kroeker

  • Levinus A. Dieleman

  • Richard N. Fedorak

Medical Centers

  • University of Alberta, Edmonton, AB, Canada

  • The University of British Columbia, Vancouver, BC, Canada

  • University of Calgary, Calgary, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Infectious Diseases (ID)

  • Genetic Disorder

Disease

  • Inflammatory bowel disease

Biomarkers

  • C reactive protein

  • Faecal calprotectin

Drug/Treatment

  • Methotrexate

  • Infliximab

  • Carnitine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved